Inverse effects of the PPARγ2 Pro12Ala polymorphism on measures of adiposity over 15 years in African Americans and whites: The CARDIA study

Metabolism: Clinical and Experimental

Volumn 54, Issue 7, 2005, Pages 910-917

  Fornage, Myriam ^a   Jacobs Jr , David R ^c,d   Steffes, Michael W ^e   Gross, Myron D ^e   Bray, Molly S ^b   Schreiner, Pamela J ^c  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF OSLO   (Norway)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADULT; AFRICAN AMERICAN; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNOLOGY; FAT INTAKE; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HOMEOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RISK ASSESSMENT;

ADIPOSE TISSUE; ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ALANINE; BASE SEQUENCE; BODY MASS INDEX; COHORT STUDIES; DNA PRIMERS; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXERCISE; FEMALE; HUMANS; MALE; POLYMORPHISM, GENETIC; PPAR GAMMA; PROLINE;

EID: 20444446401     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2005.02.005     Document Type: Article

References (37)

1. J. Auwerx PPARgamma, the ultimate thrifty gene Diabetologia 42 9 1999 1033 1049
2. L. Fajas, J.C. Fruchart, and J. Auwerx PPARgamma3 mRNA: a distinct PPARgamma mRNA subtype transcribed from an independent promoter FEBS Lett 438 1-2 1998 55 60
3. C.J. Yen, B.A. Beamer, C. Negri, K. Silver, K.A. Brown, and D.P. Yarnall Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation Biochem Biophys Res Commun 241 2 1997 270 274
4. S.S. Deeb, L. Fajas, M. Nemoto, J. Pihlajamaki, L. Mykkanen, and J. Kuusisto A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity Nat Genet 20 3 1998 284 287
5. B.A. Beamer, C.J. Yen, R.E. Andersen, D. Muller, D. Elahi, and L.J. Cheskin Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-gamma2 gene with obesity in two Caucasian populations Diabetes 47 11 1998 1806 1808
6. A. Meirhaeghe, L. Fajas, N. Helbecque, D. Cottel, J. Auwerx, and S.S. Deeb Impact of the peroxisome proliferator activated receptor gamma2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus Int J Obes Relat Metab Disord 24 2 2000 195 199
7. S. Masud, and S. Ye Effect of the peroxisome proliferator activated receptor-gamma gene Pro12Ala variant on body mass index: a meta-analysis J Med Genet 40 10 2003 773 780
8. S.A. Cole, B.D. Mitchell, W.C. Hsueh, P. Pineda, B.A. Beamer, and A.R. Shuldiner The Pro12Ala variant of peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) is associated with measures of obesity in Mexican Americans Int J Obes Relat Metab Disord 24 4 2000 522 524
9. M. Koch, K. Rett, E. Maerker, A. Volk, K. Haist, and M. Deninger The PPARgamma2 amino acid polymorphism Pro 12 Ala is prevalent in offspring of Type II diabetic patients and is associated to increased insulin sensitivity in a subgroup of obese subjects Diabetologia 42 6 1999 758 762
10. J. Ringel, S. Engeli, A. Distler, and A.M. Sharma Pro12Ala missense mutation of the peroxisome proliferator activated receptor gamma and diabetes mellitus Biochem Biophys Res Commun 254 2 1999 450 453
11. Y. Mori, H. Kim-Motoyama, T. Katakura, K. Yasuda, H. Kadowaki, and B.A. Beamer Effect of the Pro12Ala variant of the human peroxisome proliferator-activated receptor gamma 2 gene on adiposity, fat distribution, and insulin sensitivity in Japanese men Biochem Biophys Res Commun 251 1 1998 195 198
12. J. Ek, S.A. Urhammer, T.I. Sorensen, T. Andersen, J. Auwerx, and O. Pedersen Homozygosity of the Pro12Ala variant of the peroxisome proliferation-activated receptor-gamma2 (PPAR-gamma2): divergent modulating effects on body mass index in obese and lean Caucasian men Diabetologia 42 7 1999 892 895
13. A. Doney, B. Fischer, D. Frew, A. Cumming, D.M. Flavell, and M. World Haplotype analysis of the PPARgamma Pro12Ala and C1431T variants reveals opposing associations with body weight BMC Genet 3 1 2002 21
14. K. Hara, T. Okada, K. Tobe, K. Yasuda, Y. Mori, and H. Kadowaki The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes Biochem Biophys Res Commun 271 1 2000 212 216
15. J. Ek, G. Andersen, S.A. Urhammer, L. Hansen, B. Carstensen, and K. Borch-Johnsen Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) gene in relation to insulin sensitivity among glucose tolerant Caucasians Diabetologia 44 9 2001 1170 1176
16. S. Jacob, M. Stumvoll, R. Becker, M. Koch, M. Nielsen, and K. Loblein The PPARgamma2 polymorphism pro12Ala is associated with better insulin sensitivity in the offspring of type 2 diabetic patients Horm Metab Res 32 10 2000 413 416
17. L.M. Chuang, C.A. Hsiung, Y.D. Chen, L.T. Ho, W.H. Sheu, and D. Pei Sibling-based association study of the PPARgamma2 Pro12Ala polymorphism and metabolic variables in Chinese and Japanese hypertension families: a SAPPHIRe study. Stanford Asian-Pacific Program in Hypertension and Insulin Resistance J Mol Med 79 11 2001 656 664
18. M. Stumvoll, H.G. Wahl, K. Loblein, R. Becker, F. Machicao, and S. Jacob Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 gene is associated with increased antilipolytic insulin sensitivity Diabetes 50 4 2001 876 881
19. G.D. Friedman, G.R. Cutter, R.P. Donahue, G.H. Hughes, S.B. Hulley, and D.R. Jacobs Jr. CARDIA: study design, recruitment, and some characteristics of the examined subjects J Clin Epidemiol 41 11 1988 1105 1116
20. D.R. Jacobs Jr., B.E. Ainsworth, T.J. Hartman, and A.S. Leon A simultaneous evaluation of 10 commonly used physical activity questionnaires Med Sci Sports Exerc 25 1 1993 81 91
21. K. Liu, M. Slattery, D. Jacobs Jr., G. Cutter, A. McDonald, and L. Van Horn A study of the reliability and comparative validity of the cardia dietary history Ethn Dis 4 1 1994 15 27
22. G.R. Warnick Enzymatic methods for quantification of lipoprotein lipids Methods Enzymol 129 1986 101 123
23. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 7 1985 412 419
24. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) JAMA 285 19 2001 2486 2497
25. S.L. Zeger, and K.Y. Liang Longitudinal data analysis for discrete and continuous outcomes Biometrics 42 1 1986 121 130
26. J. Robitaille, J.P. Despres, L. Perusse, and M.C. Vohl The PPAR-gamma P12A polymorphism modulates the relationship between dietary fat intake and components of the metabolic syndrome: results from the Quebec Family Study Clin Genet 63 2 2003 109 116
27. J. Luan, P.O. Browne, A.H. Harding, D.J. Halsall, S. O'Rahilly, and V.K. Chatterjee Evidence for gene-nutrient interaction at the PPARgamma locus Diabetes 50 3 2001 686 689
28. A. Memisoglu, F.B. Hu, S.E. Hankinson, J.E. Manson, I. De Vivo, and W.C. Willett Interaction between a peroxisome proliferator-activated receptor gamma gene polymorphism and dietary fat intake in relation to body mass Hum Mol Genet 12 22 2003 2923 2929
29. UW-FHCRC Variation Discovery Resource. http://pga.gs.washington.edu/data/ pparg/. In.
30. V. Lindi, K. Sivenius, L. Niskanen, M. Laakso, and M.I. Uusitupa Effect of the Pro12Ala polymorphism of the PPAR-gamma2 gene on long-term weight change in Finnish non-diabetic subjects Diabetologia 44 7 2001 925 926
31. B.J. Nicklas, E.F. van Rossum, D.M. Berman, A.S. Ryan, K.E. Dennis, and A.R. Shuldiner Genetic variation in the peroxisome proliferator-activated receptor-gamma2 gene (Pro12Ala) affects metabolic responses to weight loss and subsequent weight regain Diabetes 50 9 2001 2172 2176
32. D. Altshuler, J.N. Hirschhorn, M. Klannemark, C.M. Lindgren, M.C. Vohl, and J. Nemesh The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes Nat Genet 26 1 2000 76 80
33. W.H. Kao, J. Coresh, A.R. Shuldiner, E. Boerwinkle, M.S. Bray, and F.L. Brancati Pro12Ala of the peroxisome proliferator-activated receptor-gamma2 gene is associated with lower serum insulin levels in nonobese African Americans: the Atherosclerosis Risk in Communities Study Diabetes 52 6 2003 1568 1572
34. S. Li, W. Chen, S.R. Srinivasan, E. Boerwinkle, and G.S. Berenson The peroxisome proliferator-activated receptor-gamma2 gene polymorphism (Pro12Ala) beneficially influences insulin resistance and its tracking from childhood to adulthood: the Bogalusa Heart Study Diabetes 52 5 2003 1265 1269
35. C. Sewter, F. Blows, R. Considine, A. Vidal-Puig, and S. O'Rahilly Differential effects of adiposity on peroxisomal proliferator-activated receptor gamma1 and gamma2 messenger ribonucleic acid expression in human adipocytes J Clin Endocrinol Metab 87 9 2002 4203 4207
36. A.J. Vidal-Puig, R.V. Considine, M. Jimenez-Linan, A. Werman, W.J. Pories, and J.F. Caro Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids J Clin Invest 99 10 1997 2416 2422
37. M. Stumvoll, and H. Haring The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism Diabetes 51 8 2002 2341 2347